Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults. Findings from a multicenter prospective observational study.

Viscoli C, Bassetti M, Castagnola E, Cesaro S, Menichetti F, Ratto S, Tascini C, Giacobbe D.

BMC Infect Dis. 2014 Dec 31;14(1):3852. [Epub ahead of print]

PMID:
25551699
[PubMed - as supplied by publisher]
Free PMC Article
2.

Micafungin in premature and non-premature infants: a systematic review of 9 clinical trials.

Manzoni P, Wu C, Tweddle L, Roilides E.

Pediatr Infect Dis J. 2014 Nov;33(11):e291-8. doi: 10.1097/INF.0000000000000434.

PMID:
24892849
[PubMed - in process]
Free PMC Article
3.

Micafungin: an evidence-based review of its place in therapy.

de la Torre P, Reboli AC.

Core Evid. 2014 Feb 25;9:27-39. doi: 10.2147/CE.S36304. eCollection 2014. Review.

PMID:
24596542
[PubMed]
Free PMC Article
4.

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, Mofenson LM, Nesheim S; Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics.

Pediatr Infect Dis J. 2013 Nov;32 Suppl 2:i-KK4. doi: 10.1097/01.inf.0000437856.09540.11. No abstract available.

PMID:
24569199
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis.

Benjamin DK Jr, Deville JG, Azie N, Kovanda L, Roy M, Wu C, Arrieta A.

Pediatr Infect Dis J. 2013 Nov;32(11):e419-25. doi: 10.1097/INF.0b013e31829efd14.

PMID:
23958810
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Caspofungin for the treatment of immunocompromised and severely ill children and neonates with invasive fungal infections.

Wiederhold NP, Herrera LA.

Clin Med Insights Pediatr. 2012 Jun 7;6:19-31. doi: 10.4137/CMPed.S8016. Print 2012.

PMID:
23641163
[PubMed]
Free PMC Article
7.

Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.

Lestner JM, Smith PB, Cohen-Wolkowiez M, Benjamin DK Jr, Hope WW.

Br J Clin Pharmacol. 2013 Jun;75(6):1381-95. doi: 10.1111/bcp.12025. Review.

PMID:
23126319
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Use of antifungal drugs in hematology.

Nucci M.

Rev Bras Hematol Hemoter. 2012;34(5):383-91. doi: 10.5581/1516-8484.20120095.

PMID:
23125547
[PubMed]
Free PMC Article
9.

Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients.

Cugno C, Cesaro S.

Pediatr Rep. 2012 Jan 2;4(1):e9. doi: 10.4081/pr.2012.e9. Epub 2012 Feb 17.

PMID:
22690315
[PubMed]
Free PMC Article
10.

The use of antifungal therapy in neonatal intensive care.

Testoni D, Smith PB, Benjamin DK Jr.

Clin Perinatol. 2012 Mar;39(1):83-98. doi: 10.1016/j.clp.2011.12.008. Epub 2012 Jan 11. Review.

PMID:
22341539
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antifungal therapy and outcomes in infants with invasive Candida infections.

Ascher SB, Smith PB, Watt K, Benjamin DK, Cohen-Wolkowiez M, Clark RH, Benjamin DK Jr, Moran C.

Pediatr Infect Dis J. 2012 May;31(5):439-43. doi: 10.1097/INF.0b013e3182467a72.

PMID:
22189522
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis.

Wiederhold NP, Cota JM, Frei CR.

Infect Drug Resist. 2008;1:63-77. Epub 2009 Jan 12.

PMID:
21694882
[PubMed]
Free PMC Article
13.

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.

Glöckner A.

Eur J Med Res. 2011 Apr 28;16(4):167-79. Review.

PMID:
21486731
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.

Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE Jr.

Antimicrob Agents Chemother. 2010 Aug;54(8):3451-9. doi: 10.1128/AAC.01647-09. Epub 2010 May 3.

PMID:
20439610
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Review of the pharmacology and clinical studies of micafungin.

Bormann AM, Morrison VA.

Drug Des Devel Ther. 2009 Dec 29;3:295-302.

PMID:
20054447
[PubMed]
Free PMC Article
16.

Safety and pharmacokinetics of repeat-dose micafungin in young infants.

Benjamin DK Jr, Smith PB, Arrieta A, Castro L, S√°nchez PJ, Kaufman D, Arnold LJ, Kovanda LL, Sawamoto T, Buell DN, Hope WW, Walsh TJ.

Clin Pharmacol Ther. 2010 Jan;87(1):93-9. doi: 10.1038/clpt.2009.200. Epub 2009 Nov 4.

PMID:
19890251
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pediatric antifungal agents.

Cohen-Wolkowiez M, Moran C, Benjamin DK Jr, Smith PB.

Curr Opin Infect Dis. 2009 Dec;22(6):553-8. doi: 10.1097/QCO.0b013e3283321ccc. Review.

PMID:
19741525
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk